REGN 241108 890.00C (REGN241108C890000) Stock Options, News & Quotes

US OptionsDetailed Quotes

REGN241108C890000

Watchlist

0.60
-0.55-47.83%

15min DelayClose Nov 5 16:00 ET

4.80High0.60Low

Intraday

5D
Daily

News

Sanofi, Regeneron Receive European Pediatric Approval for Throat Disease Treatment
MT Newswires3minutes ago
Express News | Regeneron - Dupixent (Dupilumab) Approved in European Union as First and Only Medicine for Young Children With Eosinophilic Esophagitis
Reuters01:01 ET
Truist Financial Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Announces Target Price $1,126
Moomoo News21:31 ET · Ratings
Regeneron Pharmaceuticals Insider Sold Shares Worth $844,610, According to a Recent SEC Filing
MT Newswires16:28 ET
Tuesday Market Closed Up, with Presidency in Sight | Wall Street Today
Kevin Travers16:25 ET
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
Analyst Upgrades15:09 ET

Comments

10xStockPicks

Oct 24 07:55

Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable

Esperion $Esperion Therapeutics (ESPR.US)$ We reiterate Strong Buy rating. Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 million Americans take statin drugs, we see continued prescription growth & expect over 5...

+20

Meltyy

Sep 25 06:31

See FDA PDUFA update 👀 👇

🚨 This Week’s PDUFAs:
$Heron Therapeutics (HRTX.US)$ : 🤔
⇨ ZYNRELEF® Vial Access Needle
‣ Postoperative pain
‣ PDUFA: 9/23/24 (sNDA)
$Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ KarXT (xanomeline-trospium)
‣ Schizophrenia
‣ PDUFA: 9/26/24 (NDA)
$Sanofi (SNY.US)$ $Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Dupixent
‣ Chronic obstructive pulmonary disease
‣ PDUFA: 9/27/24 (sBLA)
$BeiGene (BGNE.US)$ $Merck & Co (MRK.US)$ & $Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ Tislelizumab, KEYTRUDA, OPDIVO & YER...

102664919

Sep 25 03:53

Hi everyone!!

Didn't manage to post yesterday but here was how I approached last night. (I am an amateur investor) Comment below what you think or what I should do next!
Day 1 passed quickly, when I first looked at the US market, it was in the reds. I was at a lost to choose what stocks or ETFs to buy.
I first placed an order in $SPDR S&P 500 ETF (SPY.US)$ to act as a buffer, and managed to get it at the price I wanted.
I then found $Regeneron Pharmaceuticals (REGN.US)$ was dropping quite a bit s...

Moomoo News Global

Sep 19 07:24

Columns Will Rate Cuts Boost the Stock Market? A Global Equity Investment Guide

The Federal Reserve on Wednesday implemented its first rate cut in over four years, reducing the benchmark rate by 50 basis points to a range of 4.75%-5%.
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...

November FOMC Approaching: Is a 25bp cut a done deal?